Streamlining Biosimilar Development: The Developer’s Perspective One-Pager
Advancing the evolution of biosimilar development to reflect today’s current science and available evidence will provide long-term sustainability to the biosimilar industry while enabling patients to access more and a wider variety of biological drugs without impacting safety or effectiveness.